SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-037230
Filing Date
2020-08-06
Accepted
2020-08-06 07:03:28
Documents
15
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-8k_20200806.htm   iXBRL 8-K 43448
2 EX-99.1 ortx-ex991_6.htm EX-99.1 197859
3 GRAPHIC gt4mb5qohzoc000001.jpg GRAPHIC 16068
4 GRAPHIC gt4mb5qohzoc000002.jpg GRAPHIC 32967
  Complete submission text file 0001564590-20-037230.txt   450018

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ortx-20200806.xsd EX-101.SCH 5784
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20200806_lab.xml EX-101.LAB 18651
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20200806_pre.xml EX-101.PRE 11157
8 EXTRACTED XBRL INSTANCE DOCUMENT ortx-8k_20200806_htm.xml XML 3472
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 201079746
SIC: 2836 Biological Products, (No Diagnostic Substances)